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Although some progress has been made in the
development of a case deﬁnition for multiple
chemical sensitivity (MCS) (Bartha et al.
1999) and in elucidating symptom profiles
(Joffres et al. 2001), we still lack a widely
accepted treatment protocol for the condition.
Consequently, patients experiment with a wide
variety of both conventional and holistic health
treatments. Although practitioners of environ-
mental medicine have a systematic approach
for working with MCS, there is no common
MCS treatment protocol accepted across med-
ical disciplines. The field of environmental
medicine espouses guidelines and techniques
for addressing MCS, but critics maintain that
the techniques have not been efficacious in
double blind trials. Because research on treat-
ments for MCS is sparse, people have few data
on which to rely when choosing interventions.
Physicians have described health ﬁndings from
patient samples (Bell et al. 1995; Galland
1987; Heuser et al. 1992; Lieberman and
Craven 1998; Ross 1992a) and suggested treat-
ment strategies (Jewett 1992; Ross 1992b;
Ziem 1992), but only a small number of pub-
lished studies describe MCS treatment and fol-
low-up (Lax and Henneberger 1995). In
addition, only three studies to date have exam-
ined patients’ assessments of a large number of
health interventions for MCS (Gibson 2000;
Johnson 1996, 1997a, 1997b, 1998; Leroy et
al. 1996). All three studies found that chemical
avoidance measures were rated as very highly
effective, whereas prescription drugs were rated
the least effective of all treatments.
Life impact research shows that people with
MCS tend to spend a considerable amount of
their resources on health care, often pursuing a
large number of therapies. Gibson et al. (1996)
found that 305 persons with MCS reported
spending almost $6,000, or half of their per-
sonal income in the past year, and almost
$35,000 total on medical expenditures since
developing MCS. Respondents saw a mean of
8.6 practitioners each, but perceived only a
quarter of them to be helpful. Still, patients
report having medical needs that remain unmet
and experiencing considerable iatrogenic harm
(Engel et al. 1996).
Our purpose in this study was to examine
the types and numbers of treatments used by
people with MCS and to investigate perceived
efﬁcacy of those treatments. The study was not
limited to conventional techniques. Rather, we
sought to gather data on any techniques that
respondents had tried, in an effort to under-
stand the experience of seeking medical treat-
ment for a poorly understood condition. We
chose to evaluate retrospective reports from
patients to assess the large number of treatment
methods tried by this population of consider-
able size. Results may be helpful to patients,
providers, and advocates in making decisions
about resource allocation.
Methods
Participants. Participants were 917 persons
contacted through the Chemical Injury
Information Network (CIIN, White Sulphur
Springs, MT; ciin.org) and through MCS
support groups. People learn about and
become members of CIIN and other support
groups through other persons with MCS,
physicians’ offices, small media, and the
Internet. Most groups publish newsletters
with resources and informational support for
persons with MCS and other interested par-
ties. Respondents were 82% women and 95%
Caucasian. Participants’ ages ranged from 20
to 82 years, with a mean age of 53 years.
Respondents’ characteristics are presented in
detail in Table 1. When asked to identify the
severity of their condition, 7% identified
their MCS as mild, 32% as moderate, 45% as
severe, and 13% as totally disabling.
Procedure. This research, including the
survey materials, was reviewed by the James
Madison University Institutional Review
Board. All members of CIIN were invited to
respond to a mail survey that gathered
informed consent and asked about their use
of 108 treatments to improve their MCS. In
addition, other MCS support groups were
contacted by CIIN and asked to distribute
the survey to their members. More than
4,000 surveys were distributed.
Measures. The survey included questions
about demographics, the impact of MCS on
ﬁnances, number of practitioners seen, appli-
cation for any type of compensation for the
illness, who identified the condition, and
respondents’ impressions regarding the cause
of their MCS. The survey used a computer
answer sheet to collect data about partici-
pants’ perceived efﬁcacy ratings of any of 108
different treatments they might have tried.
The 108 treatments included were gathered
from the three efficacy studies done to date
(Gibson 2000; Johnson 1996, 1997a, 1997b,
1998; Leroy et al. 1996), elements of envi-
ronmental medicine protocol, widely used
nutritional supplements, well-known body
therapies and other holistic therapies, and
other current treatments described to us by
persons with MCS. Treatments were grouped
into the following nine categories: environ-
mental medicine/oasis techniques, holistic
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Multiple chemical sensitivity (MCS) is a condition in which persons experience negative health
effects in multiple organ systems from exposure to low levels of common chemicals. Although
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others. The three most highly rated treatments were creating a chemical-free living space, chemical
avoidance, and prayer. Both creating a chemical-free living space and chemical avoidance were
rated by 95% of respondents as helpful. Results for most therapies were mixed. Participants had
consulted a mean of 12 health care providers and spent over one-third of their annual income on
health care costs. We discuss this drain on personal resources and describe respondents’ attitudes
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http://dx.doi.org/ [Online 9 April 2003]therapies, individual nutritional supplements,
detoxification techniques, body therapies,
Eastern-origin techniques, newer therapies,
prescription items, and others. Unless other-
wise speciﬁed, respondents were asked to rate
the efﬁcacy of a treatment in terms of its use-
fulness in improving their MCS, rather then
simply as an aid in coping with exposures.
Exceptions were the use of air ﬁlters, oxygen,
and charcoal masks, which were conceptual-
ized not as treatments per se, but as aids in
reducing exposures. For each treatment, par-
ticipants were asked whether they had tried it
and, if so, for how long. Those who had used
a treatment were then asked to rate the effi-
cacy of the treatment as “very harmful,”
“somewhat harmful,” “no noticeable effect,”
“somewhat helpful,” or “very helpful.” For
therapies conceptualized as time-limited
interventions (e.g., clinic sauna), we asked
how long negative or positive effects had
persisted after completion of the therapy.
Results
We received 967 surveys. Of these, 47 were
incomplete and 3 were from children under
age 18 years, yielding 917 usable surveys.
Quantitative data were calculated using SPSS
software (version 6.13; SPSS, Inc., Chicago,
IL). Respondents’ comments were read for
content and themes regarding people’s beliefs
about recovering from MCS.
Quantitative data. When participants
were asked what they believed to be the cause
of their chemical sensitivity, 20.2% identiﬁed
one large chemical exposure, 58.5% a series of
low-level exposures, 5.2% a physical illness,
0.8% a psychological stressor, 8.7% did not
know, and 6.7% did not answer the question.
When asked who initially identified their
MCS, 34% of participants reported identify-
ing the problem themselves, 26% received
diagnoses from health providers, 6% said the
problem was identiﬁed by a friend or family
member, 4% were helped by the media, and
29% said that it was some combination of the
above. The course of their condition over the
previous 2 years was described as evidencing a
considerable decline by 20% of participants, a
slight decline by 17%, mixed or no change
by 24%, a slight improvement by 25%, and
considerable improvement by 15%.
Only 23% of respondents were working
outside of the home. Mean annual household
income was $46,000; mean personal income
was $20,000. For many, a substantial amount
of this personal income was worker’s com-
pensation or disability income. Thirty-one per-
cent of respondents (286 people) had been
involved in a worker’s compensation claim; 115
received compensation and 54 had cases pend-
ing. Fifty-ﬁve percent (505 people) had ﬁled for
Social Security disability; 376 received it and 38
had cases pending. Private disability was sought
by 23% of respondents (or 206 people); 156
were granted and 13 had cases pending.
Participants had consulted a mean of 12
health care providers, but the mean number
described as helpful was only 3. A considerable
amount of income was spent on medical treat-
ments. Participants had spent a mean total of
$51,000 on health care, $7,000 in the past
year. This means that 15% of their annual
household income went to health care costs. In
addition, respondents had spent a mean of
$57,000 in their attempts to create safe homes.
Treatments used by fewer than 25 respon-
dents were excluded because of small sample
sizes, leaving 101 treatments for analysis.
Respondents had used a mean of 31.4 of these
treatments, including 9.6 nutritional supple-
ments, 5.6 environmental medicine techniques,
3.2 holistic therapies, 3.4 body therapies, 2.5
prescription items, 1.6 detoxiﬁcation processes,
1 Eastern-origin technique, 0.3 newer therapies,
and 4 therapies categorized as “other therapies.”
Table 2 reports the number of respondents
who tried each treatment and their perceived
efﬁcacy ratings. We also computed a ratio for
each treatment of the number of persons
reporting help to the number reporting harm.
Ratings of “no noticeable effect” were not
included in this ratio. Treatments with the
highest help:harm ratios have more positive
and fewer negative effects, according to
respondents’ perceived efficacy ratings. For
example, a ratio of 2 means that the treatment
was rated as helpful by twice as many people
as rated it harmful. Those with help:harm
ratios < 1 were rated more likely to harm than
help. Therefore, a ratio of only 0.25 would
mean that the treatment was rated as helpful
by only one-quarter of the number, or 25% of
the number who rated it as harmful.
The three most highly rated treatments
were creating a chemical-free living space,
chemical avoidance, and prayer. Both creating
a chemical-free living space and chemical
avoidance were rated by 95% of people as
helpful. The chemical-free living space was
155 times more likely to be rated as helpful
than as harmful, and chemical avoidance was
119 times more likely to be rated as helpful
than harmful. Prayer was 48 times more likely
to be rated as helpful than harmful, with 94%
of people rating it as helpful. Other therapies
rated as highly effective and with help:harm
ratios above 10 included rotation diet, air ﬁl-
ters to prevent exposures, personal oxygen to
cope with exposures, acidophilus, acupressure,
touch for health, reflexology, moving to a
safer location, and meditation. Table 3 shows
the 35 therapies with help:harm ratios ≥ 5.
Therapies rated as more harmful than
helpful with help:harm ratios of < 1 included
provocation–neutralization (P-N) testing for
chemicals with preservative, UltraClear, hydro-
gen peroxide, Microhydrin, all the antidepres-
sants, antiseizure medications other than
Neurontin, acyclovir, Valium, Xanax, and glu-
tathione in a nasal spray (as opposed to a nebu-
lizer). These therapies are listed in Table 4.
When we examined responses of partici-
pants who had used treatments long-term
(5–11 months or more), most of the treat-
ments (n = 82) fit a pattern of a decrease in
harmful effects and an increase in helpful
effects (although the amount of change varied).
“No noticeable effect” ratings varied consider-
ably. Chemical avoidance and a chemical-free
living space shifted only slightly in ratings
because these interventions were rated so highly
that there was almost no room to improve.
Only four treatments did not ﬁt the above
pattern. One exception was P-N testing for
chemicals with preservative, which increased in
both harmful and helpful ratings with long-
term use. The harmful effects of best chiroprac-
tic technique were eliminated; however, there
was a 17.5% increase in “no noticeable effects,”
bringing the total to 55.6%. Antibiotic therapy
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Table 1. Respondent characteristics.
Characteristics Numbera Percent
Sex
Male 169 18.4
Female 748 81.6
Race
African American 4 0.4
Latin American 6 0.7
Native American 18 2.0
Caucasian 867 94.5
Asian American 3 0.3
Other 19 2.1
Partner status
Single 184 20.2
Married 490 53.8
Divorced 197 21.6
Separated 13 1.4
Widowed 26 2.9
Education
< 12 years 16 1.8
12 years 76 8.3
12–15 years 285 31.2
16 years 273 29.9
Masters degree or beyond 264 28.9
Cause of MCS
One large chemical
exposure 185 20.2
Series of low-level
exposures 536 58.5
Physical illness 48 5.2
Psychological stress 7 0.8
Unknown 80 8.7
Missing data 61 6.7
Level of disability
Mild 65 7.2
Moderate 295 32.9
Severe 414 46.1
Totally disabled 123 13.7
Course of condition in
last 2 years
Considerable decline 181 19.8
Slight decline 152 16.6
Mixed course or no change 218 23.9
Slight improvement 225 24.6
Considerable improvement 137 15.0
aTotal number of participants was 917.for Mycoplasma fermentans showed an increase
in “very harmful” ratings (an increase of 4%
brought “very harmful” effects to 25.4%).
“Somewhat harmful” ratings declined, however,
and “very helpful” increased by 2.5%.
Alexander technique ratings for “very harmful”
increased by 1.8%, but “somewhat harmful”
ratings decreased from 4.9 to 0%. Data from
this analysis are available from the ﬁrst author.
Interventions that were time-limited by
nature, such as sauna therapy at a clinic and
relocating, were reassessed separately to exam-
ine how long both helpful and harmful effects
endured. These results are presented in
Table 5.
Mean number of treatments tried increased
with level of self-reported severity of MCS.
People with mild MCS reported using a mean
of 24.8 (SD = 14.6) different treatments;
moderate, 29.0 (SD = 14.2) treatments; severe,
32.6 (SD = 13.7) treatments; and those totally
disabled, 37.0 (SD = 13.2) treatments.
A correlational analysis was conducted
using total number of treatments tried, total
number from each category, income, number
of practitioners seen, number of practitioners
helpful, and amount of money spent on health
care as continuous variables. Course of illness
was coded as a dichotomous variable for this
analysis, with either a slight or considerable
improvement over the past 2 years coded as 1,
and a slight or considerable decline or mixed
course as 0. An improved course of condition
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Table 2. Perceived efﬁcacy of 101 treatments tried by 917 persons with MCS.
Number Very Somewhat No noticeable Somewhat Very Help:harm
tried harmful (%) harmful (%) effect (%) helpful (%) helpful (%) ratioa
Environmental medicine and oasis techniques
Chemical avoidance 875 0.5 0.3 4.7 38.0 56.5 118.6
Chemical-free living space 820 0.1 0.5 4.5 38.6 56.2 155.2
P-N for chemicals with preservative 159 22.0 18.1 25.4 27.1 7.3 0.9
P-N for chemicals without preservative 218 11.9 12.8 28.3 31.4 15.5 1.9
P-N without glycerin or preservative 178 12.5 8.3 25.0 30.2 24.0 2.6
Sauna at clinic 151 7.1 7.7 20.6 30.3 34.2 4.4
Sauna at home 245 7.1 11.4 19.6 38.8 23.1 3.4
Rotation diet 560 1.6 4.1 22.1 44.0 28.2 12.7
Air ﬁlter (to prevent exposure) 786 1.8 4.2 11.8 47.5 34.6 13.7
Charcoal mask 598 4.5 8.3 9.8 55.1 22.3 6.0
Aluminum foil to seal off-gassing 253 5.6 5.3 14.7 35.7 38.7 6.8
Personal oxygen to cope with exposures 326 2.9 4.4 14.2 39.8 38.6 10.6
Individual nutritional supplements
Intravenous magnesium 175 4.2 6.8 25.5 40.6 22.9 5.8
Buffered vitamin C powder 516 4.0 8.8 29.4 37.3 20.5 4.5
Other vitamin C 683 2.8 6.7 38.8 35.3 16.4 5.5
Vitamin E supplements 709 2.1 5.1 53.1 29.3 10.3 5.4
Coenzyme Q10 517 2.5 5.8 51.4 28.8 11.5 4.9
Magnesium supplements 644 2.3 3.8 41.4 34.4 18.0 8.6
Calcium supplements 663 2.6 5.2 56.6 25.0 10.6 4.6
Chromium supplements 399 3.8 4.5 57.8 22.2 11.8 4.1
Other mineral supplements 666 2.0 5.7 43.4 35.0 13.9 6.4
Grapefruit seed extract 325 7.7 11.6 43.3 27.6 9.8 1.9
Echinacea 515 5.6 11.8 48.6 23.0 11.0 2.0
Goldenseal 299 5.8 13.5 48.4 21.5 10.9 1.7
Siberian ginseng 283 5.9 15.0 48.3 26.2 4.5 1.5
Milk thistle seed 458 3.2 6.5 41.6 33.6 15.1 5.0
Garlic 555 5.2 10.2 46.5 25.9 12.2 2.5
Acidophilus 661 0.9 3.2 44.0 32.8 19.2 12.7
DHEA 352 8.2 15.1 46.4 20.7 9.5 1.3
Thyroid supplements 406 3.8 8.4 39.8 28.1 19.9 3.9
Holistic therapies
Homeopathy with homeopathic doctor 401 4.9 9.1 32.6 33.8 19.5 3.8
Over-the-counter homeopathy 425 4.0 6.8 36.6 40.1 12.6 4.9
Bach ﬂower remedies 236 2.5 6.6 50.2 29.6 11.1 4.5
Acupuncture 422 3.9 6.3 36.0 32.5 21.3 5.3
Herbal medicines 650 4.2 7.6 24.5 41.8 22.0 5.5
Macrobiotic diet 182 13.5 15.1 24.0 33.3 14.1 1.7
Juicing 315 4.4 8.8 42.0 31.2 13.6 3.4
Aromatherapy 127 19.8 20.6 19.1 30.5 9.9 1.0
Chelation 131 11.0 13.2 27.2 31.6 16.9 2.0
Neural therapy 56 10.7 10.7 28.0 36.0 14.7 2.4
Detoxiﬁcation
Remove mercury dental ﬁllings 425 3.1 6.1 47.1 27.3 16.5 4.8
Hulda Regehr Clark’s parasite program 87 18.7 9.3 36.4 27.1 8.4 1.3
Coffee enemas 146 5.4 14.3 32.0 32.7 15.6 2.5
Colonics 222 4.8 8.4 28.2 38.3 20.3 4.4
Liver ﬂushes 148 9.6 9.6 25.5 35.7 19.7 2.9
Gallbladder ﬂushes 95 3.8 9.5 33.3 36.2 17.1 4.0
UltraClear 232 8.7 27.0 30.3 22.8 11.2 1.0
Hydrogen peroxide therapy 123 17.4 13.2 40.3 15.3 13.9 1.0
Eastern origin techniques
Meditation 423 0.7 2.1 43.3 41.2 12.6 19.2
Yoga asans (postures) 260 3.0 5.9 41.9 37.4 11.9 5.5
Tai chi 154 3.2 9.0 54.5 21.8 11.5 2.7
Qi gong 109 3.3 6.5 40.7 36.6 13.0 5.1
Continued, next pagehad a small positive correlation with number
of treatments tried and strong positive correla-
tions with all categories of treatments; the
highest correlations were with nutritional sup-
plements (r = 0.112, p = 0.001), holistic treat-
ments (r = 0.089, p = 0.007), body therapies
(r = 0.069, p = 0.037), detoxification tech-
niques (r = 0.066, p = 0.046), and other treat-
ments (r = 0.041, p = 0.221).
Course of illness had a small nonsignifi-
cant negative correlation with number of
practitioners seen (r = –0.040, p = 0.236), but
a signiﬁcant positive correlation with number
of practitioners rated as helpful (r = 0.101, p =
0.003). Total money spent on care had an
insigniﬁcant negative correlation with course
of illness (r = –0.042, p = 0.279)
Qualitative data. Respondents wrote long
descriptions of their efforts to cope with and
recover from MCS. Several themes emerged
repeatedly in respondents’ descriptions of their
views of the possibility of and requirements for
recovery. One fairly widely held view was that
there is no treatment for MCS save for chemi-
cal avoidance. Persons commented on spend-
ing large amounts of money with no effect
from any of the treatments tried and noted
specifically that only avoidance was useful.
These respondents seemed also to feel that it
was a waste of resources to pursue numerous
questionable treatments. Some of these respon-
dents had actually tried very few treatments.
Others may have developed this view after
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Table 2. Continued.
Number Very Somewhat No noticeable Somewhat Very Help:harm
tried harmful (%) harmful (%) effect (%) helpful (%) helpful (%) ratioa
Body therapies
Traditional chiropractic 498 2.2 6.1 47.4 31.8 12.5 5.3
Chiropractic with applied kinesiology 278 3.2 3.6 41.7 35.6 15.8 7.5
Network chiropractic 63 11.6 15.1 36.0 23.3 14.0 1.4
Chiropractic with contact reﬂex analysis 57 18.6 5.7 32.9 28.6 14.3 1.8
Best chiropractic 29 7.1 14.3 38.1 23.8 16.7 1.9
Applied kinesiology without chiropractic 191 7.1 5.6 32.0 34.0 21.3 4.4
Alexander technique 38 4.9 4.9 68.3 19.5 2.4 2.3
Trager 31 7.1 14.3 50.0 23.8 4.8 1.3
Reiki 170 2.7 4.8 44.6 34.4 13.4 6.4
Acupressure 308 1.0 3.5 28.3 46.0 21.2 14.9
Massage 501 0.8 7.9 32.5 39.4 19.4 6.8
Touch for health 75 2.5 1.3 41.8 35.4 19.0 14.3
Polarity balancing 117 3.3 4.9 45.9 29.5 16.4 5.6
Reﬂexology 204 2.4 2.4 38.5 43.4 13.2 11.6
Rolﬁng 60 7.8 14.1 35.9 26.6 15.6 1.9
Osteopathic adjustment 171 5.0 5.5 44.2 30.4 14.9 4.3
Craniosacral work 270 4.0 2.6 36.6 36.6 20.1 8.6
Total body modiﬁcation 42 8.6 6.9 29.3 36.2 19.0 3.6
Newer therapies
Mycrohydrin 57 10.8 15.4 53.8 10.8 9.2 0.8
Oxygen therapy 162 5.6 5.1 20.3 44.1 24.9 6.4
Eye movement desensitization and reprocessing 64 15.8 7.9 51.3 17.1 7.9 1.1
Neurolinguistic programming 37 8.8 2.9 64.7 17.6 5.9 2.0
Prescription items
Nizoral 153 16 17.8 25.2 31.3 9.8 1.2
Nystatin 402 7.9 14.5 33.2 31.9 12.5 2.0
Diﬂucan 249 9.9 14.5 28.9 31.4 15.3 1.9
Prozac 183 37.6 21.5 25.8 9.7 5.4 0.3
Zoloft 148 45.5 22.7 23.4 5.8 2.6 0.1
Elavil 149 33.9 23.6 27.3 9.7 5.5 0.3
Other antidepressants 306 32.4 17.6 27.2 17.6 5.1 0.5
Neurontin 100 19.6 15.7 24.5 24.5 15.7 1.1
Other antiseizure medicine 76 37.6 12.9 24.7 16.5 8.2 0.5
Antibiotic therapy for Mycoplasma fermentans 38 17.4 13.0 21.7 21.7 26.1 1.6
Acyclovir (Zovirax) 68 19.8 13.6 40.7 18.5 7.4 0.8
Transfer factor 64 13.2 13.2 26.5 30.9 16.2 1.8
Valium 125 23.1 21.6 34.3 17.2 3.7 0.5
Xanax 134 25.0 20.8 27.8 19.4 6.9 0.6
Glutathione in nasal spray 54 16.2 17.6 35.3 25.0 5.9 0.9
Glutathione in nebulizer 33 18.0 10.0 22.0 26.0 24.0 1.8
Other
Changed residence 513 2.9 4.5 6.0 42.3 44.3 11.7
Enzyme potentiated desensitization 61 19.1 10.3 17.6 20.6 32.4 1.8
Nambudripad desensitization 207 3.8 3.8 38.6 31.0 22.9 7.1
Magnets 265 11.1 9.0 48.4 20.4 11.1 1.6
Prayer 609 0.7 0.7 34.4 35.6 28.6 48.3
Faith healer 127 3.1 1.6 51.6 25.8 18.0 9.3
Exercise 763 4.3 10.4 23.7 40.3 21.3 4.2
Hypnosis 111 7.1 6.3 60.3 16.7 9.5 1.9
Psychotherapy to cure MCS 200 6.6 8.0 65.3 15.5 4.7 1.4
Psychotherapy to cope with MCS 362 3.8 7.0 24.1 47.7 17.3 6.0
Support group 520 1.5 7.2 15.5 42.3 33.6 8.7
aRatio of number reporting help to persons reporting harm.investing resources in numerous unsuccessful
attempts to heal. This view was exempliﬁed in
the response from one woman who responded
to the question “Are there treatments other
than those listed above that you have tried?”
with “There are others? God help us!” A con-
siderable number of participants reported hav-
ing no money to invest in treatment. Some
who did have resources felt that to improve it
was necessary to “do everything,” meaning that
they combined chemical avoidance with a
strict nutritional program and select holistic
and/or conventional medicine techniques.
Some were critical of the view that there is no
cure. One respondent said
For those who say “there is no cure,” I think of it
in terms of someone who has an amputated leg,
being offered a prosthetic, and saying well it’s not
a real leg, no cure. I may not be “cured” but I am
at a much better place than at my worst, and it
shows me that the body can heal substantially, if
given support.
A few gave very esoteric descriptions of
using a series of little-known therapies and
having perhaps not complete remission, but
substantial improvement. Well-known MCS
doctors were mentioned and credited with
improving respondents’ health, even to the
extent of saving their lives. A small number of
respondents had tried a great number of treat-
ments to no avail, but still believed that their
current therapy would be the one that made
the difference. A few reported being healed in
a religious manner.
One respondent’s description of MCS
suggests Miller’s (1996) conceptualization of
chemical sensitivity as a broad mechanism for
disease rather than a discrete illness. The quo-
tation seems to capture both the complexity
and the seriousness of the impact of MCS
upon the body:
I think MCS, like most health breakdowns, is
probably best conceptualized not as a discrete
“Illness” or “disease” which can be mastered to X
degree by particular “treatments”; rather it is a
complex set of ways in which a person may break
down if his [sic] life patterns are unhealthy in
major ways. Noxious chemical exposures and
other external stressors interact with one’s particu-
lar physical, mental, emotional, and spiritual
habits and vulnerabilities to produce symptoms
(discomfort; impaired functions). Getting health-
ier is much more global than just getting so-called
treatments (usually mostly physical)—and of
course physical healing may be severely restricted
even with good new health habits if enough bodily
damage has occurred.
These views correspond roughly with those
held by various practitioners and members of
the MCS community and represent different
constructions of the problem of MCS.
Discussion
This research found that people are trying a
large number of interventions for MCS and
spending a large portion of their limited
income on these treatments. Although number
of treatments tried was positively related to an
improved course of illness, total money spent
and number of practitioners seen were not.
The highest-rated therapies were fairly nonin-
vasive and low risk. Consistent with earlier
studies, creating a safe living space and chemical
avoidance were rated as the most effective treat-
ments for MCS. Lowest perceived efﬁcacy rat-
ings were given to prescription drugs and other
higher-risk interventions. Although chemical
avoidance at home through creation of a safe
living space was low risk and rated effective, it
did require a considerable ﬁnancial investment
($57,000 was the average investment).
When longer-term use of the treatments
was examined, most treatments decreased in
harmful ratings and increased in helpful rat-
ings. This may have occurred because respon-
dents may have discontinued the use of
treatments not perceived as helpful. However,
for some treatments, longer-term experimen-
tation tended to reduce the “no noticeable
effect” category; perhaps extended time is
needed to decipher actual effects.
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Table 3. The highest rated of 101 treatments.
Number Help:harm
Treatment tried Harmed (%) No effect (%) Helped (%) ratio
Chemical-free living space 820 0.6 4.5 94.8 155.2
Chemical avoidance 875 0.8 4.7 94.5 118.6
Prayer 609 1.4 34.4 64.2 48.3
Meditation 423 2.8 43.3 53.8 19.2
Acupressure 308 4.5 28.3 67.2 14.9
Touch for health 75 3.8 41.8 54.4 14.3
Air ﬁlter (to prevent exposure) 786 6.0 11.8 82.1 13.7
Rotation diet 560 5.7 22.1 72.2 12.7
Acidophilus 661 4.1 44.0 52.0 12.7
Relocation 513 7.4 6.0 86.6 11.7
Reﬂexology 204 4.8 38.5 56.6 11.6
Personal oxygen to cope with exposures 326 7.3 14.2 78.4 10.6
Faith healing 127 4.7 51.6 43.8 9.3
Support group 520 8.7 15.5 75.9 8.7
Craniosacral work 270 6.6 36.6 56.7 8.6
Magnesium supplements 644 6.1 41.4 52.4 8.6
Chiropractic with applied kinesiology 278 6.8 41.7 51.4 7.5
Nambudripad desensitization (NAET) 207 7.6 38.6 53.9 7.1
Aluminum foil to seal offgassing 253 10.9 14.7 74.4 6.8
Massage 501 8.7 32.5 58.8 6.8
Oxygen therapy 162 10.7 20.3 69.0 6.4
Reiki 170 7.5 44.6 47.8 6.4
Other mineral supplements 666 7.7 43.4 48.9 6.4
Charcoal mask 598 12.8 9.8 77.4 6.0
Psychotherapy to cope with MCS 362 4.5 24.1 65.0 6.0
Intravenous magnesium 175 11.0 25.5 63.5 5.8
Polarity balancing 117 8.2 45.9 45.9 5.6
Herbal medicines 650 11.8 24.5 63.8 5.5
Other vitamin C 683 9.5 38.8 51.7 5.5
Vitamin E supplements 709 7.2 53.1 39.6 5.4
Yoga asans (postures) 260 8.9 41.9 49.3 5.5
Traditional chiropractic 498 8.3 47.4 44.3 5.3
Acupuncture 422 10.2 36.0 53.8 5.3
Qi gong 109 9.8 40.7 49.6 5.1
Milk thistle seed 458 9.7 41.6 48.7 5.0
Table 4. Treatments rated more likely to harm than help.
Number Help:harm
tried Harmed (%) No effect (%) Helped (%) ratio
Zoloft 148 68.2 23.4 8.4 0.1
Prozac 183 59.1 25.8 15.1 0.3
Elavil 149 57.5 27.3 15.2 0.3
Other antidepressants 306 50.0 27.2 22.7 0.5
Valium 125 44.7 34.3 20.9 0.5
Antiseizure medications (other than Neurontin) 76 50.5 24.7 24.7 0.5
Xanax 134 45.8 27.8 26.3 0.6
Microhydrin 57 26.2 53.8 20.0 0.8
Acyclovir (Zovirax) 68 33.4 40.7 25.9 0.8
P-N for chemicals with preservative 159 40.1 25.4 34.4 0.9
Glutathione in nasal spray 54 33.8 35.3 30.9 0.9
UltraClear 232 35.7 30.3 34.0 1.0
Hydrogen peroxide 123 30.6 40.3 29.2 1.0It is important to qualify that we asked
speciﬁcally about whether a treatment actually
improved or cured MCS. The fact that a treat-
ment does not cure MCS does not mean that
it does not provide symptomatic relief or sup-
port the patient’s general physical state. In
fact, many people noted in the qualitative
comments that it was only the combination of
treatments that helped them improve. Many
reported that it was necessary to do environ-
mental controls, a correctly tailored program
of nutritional supplements, and a number of
other interventions that addressed their own
unique constellation of symptoms. Therefore,
we do not advocate discontinuing treatments
perceived to be helpful simply because they are
not reported here to actually cure MCS. On
the other hand, we did want to identify inter-
ventions with high harm rates, so patients can
take that information into consideration when
deciding where to allocate their time, energy,
and ﬁnancial resources.
The nonsignificant correlation between
course of illness and number of practitioners
seen may support the view that simply going
from practitioner to practitioner is not curative.
However, because correlation does not imply
causation, those in downward health spirals
may have felt a need to contact more providers.
The significant positive correlation between
number of practitioners rated as helpful and
course of illness makes intuitive sense, though
patients who are not currently in a downward
slide may be easier to help and therefore more
likely to rate their providers as helpful.
The results show primarily that a safe liv-
ing space and chemical avoidance are reported
by patients to be the most efficacious treat-
ments for chemical sensitivity. Two relevant
issues here are the difﬁculty of chemical avoid-
ance and the lack of availability of safe housing.
Because of the presence of toxic substances in
virtually every environment, chemical avoid-
ance requires substantial isolation. Persons
wanting to preserve employment, social inter-
action, or any community involvement face
the almost impossible nature of avoiding
debilitating exposures. The understanding of
chemical barriers is in its infancy, as is general
MCS research, so safe public spaces for the
chemically sensitive are rare. Chemical barriers
in the home are ever present as well. The use
of toxic materials in buildings and the ubiqui-
tous nature of chemical exposures render most
living situations unsuitable for those with
MCS. Gibson et al. (1996) found that 66% of
their sample of 305 persons with MCS had
lived in unusual conditions such as in their
cars, in RVs, on porches, or in tents at some
time during their illness. A housing survey
done by the housing committee of the
Environmental Health Coalition of Western
Massachusetts found similarly that 10% of
their sample of 49 persons with MCS were
homeless at the time of the survey, and
another 10% lived in situations such as
campers, trailers, and cabins (Wachsler 2001).
The housing problem afflicts those at lower
income levels inequitably; the survey found
that 47% of those with annual incomes of
under $12,000 had substandard or no hous-
ing. The housing committee also found that
almost three-quarters of respondents had had
to live in places that made them sick, and
almost half had to spend beyond their means
to remain in safe housing. A little over half
(55%) considered their current housing to be
safe. Gibson et al. (1996) found that only
41% of MCS respondents reported living in
safe housing, whereas 44% said it should be
better, 11% said it was mostly unsafe, and 5%
said it was not at all safe. CIIN is currently
investigating why people with MCS stay in
unsafe housing. One theme that has emerged
in the inquiry by CINN is that some people
attempt to compensate for unsafe homes with
filters, supplements, and treatments (Wilson
2001). However, the ratings in this study
clearly suggest that supplements and treat-
ments do not compare in perceived efﬁcacy to
safe housing and chemical avoidance. Safe
housing and chemical avoidance may therefore
be more pertinent to MCS patients than treat-
ment: The rated efficacy of even the most
highly rated treatments was only a fraction of
that of safe housing and chemical avoidance.
Limitations. Limitations of this study
involved the use of computerized answer
sheets, the use of retrospective self-report sur-
veys, the use of an unscreened convenience
sample, a low response rate, respondents’ con-
current use of multiple treatments, and the
inclusion of persons who had tried the treat-
ments for varying lengths of time. In addition,
although we stored the surveys in baking soda
before distribution, the answer sheets did not
receive this treatment and were problematic
for some people. This problem may not only
have eliminated possible respondents, but
interfered with participants’ ability to answer
questions clearly. As one respondent said “Do
you know how hard it is to answer this survey
with brain fog?”
Some data also were lost because of respon-
dents’ lack of familiarity with computerized
forms and their choice of two or more answers
for one question. For example, some people
checked that a treatment was both helpful and
harmful. These respondents may have been
trying to report on multiple attempts of a treat-
ment, multiple effects from a treatment, or
treatment from more than one practitioner.
However, multiple answers were unreadable by
the computer and ultimately contributed to
missing data.
In addition, respondents noted having dif-
ficulty separating effects of specific therapies
when a combination of treatments was being
used. Respondents may have also had other
comorbid conditions, treatment of which
could either hamper or augment treatments
taken for the MCS.
The response rate for the study was low,
with 917 persons out of about 4,000 respond-
ing. We do not know all of the self-selection
factors that might have operated. Some non-
respondents reported that they had been away
from their homes (and missed their mail)
because their homes or neighborhoods had
become unsafe for them during the window
of time allotted for completion of the survey.
For example, one person had left her home
because of road construction and paving and
had been living in a tent for several weeks.
Therefore, persons unable to access their
homes because of toxics would have been
screened out of the survey. A number of other
variables might have operated to screen per-
sons either into or out of the study. In addi-
tion, it is not known whether persons not
associated with support groups would respond
similarly to the studied sample.
Statistical associations found through cor-
relational analyses in this study need to be
confirmed through further research. Some
statistically significant associations may be
due to a large number of participants and not
meaningful.
Conclusion
Nonetheless, this work provides some infor-
mation about the perceptions of MCS patients
Environmental Medicine | Perceived treatment efficacy in chemical sensitivity
Environmental Health Perspectives • VOLUME 111 | NUMBER 12 | September 2003 1503
Table 5. Length of helpful and harmful effects of time-limited therapies.
No. < 1 month (%) 1–3 months (%) 4–6 months (%) 7–12 months (%) > 1 year (%)
Sauna
Helped 74 20.3 17.6 13.5 14.9 33.8
Harmed 13 23.1 23.1 7.7 7.7 38.5
Nambudripad
desensitization
Helped 40 2.5 10.0 10.0 20.0 57.5
Harmed 4 0.0 50.0 0.0 25.0 25.0
Craniosacral
Helped 75 45.3 21.3 6.7 4.0 22.7
Harmed 2 0.0 0.0 0.0 50 50
Changed residence
Helped 170 4.7 6.5 8.2 12.4 68.2
Harmed 3 66.7 33.3 0.0 0.0 0.0Environmental Medicine | Gibson et al.
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regarding a large number of interventions.
Future research should attempt to address
some of the limitations of this study while still
making use of patient input. In addition,
future research samples need to be more
racially diverse. Despite the wide prevalence of
MCS (Kreutzer and Neutra 1996; Meggs et
al. 1996; Voorhees 1999) and its conceptual-
ization as an emerging public health problem
(Ashford and Miller 1994), progress in pre-
vention and treatment of the condition has
been minimal. It is important to find effica-
cious treatments that minimize the financial
depletion of a population that has difficulty
remaining in gainful employment.
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